Filing Details

Accession Number:
0000899243-21-022065
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-04 17:00:28
Reporting Period:
2021-06-02
Accepted Time:
2021-06-04 17:00:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1847903 Centessa Pharmaceuticals Plc CNTA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1826323 Marella Thorell C/O Centessa Pharmaceuticals Plc
3Rd Fl., 1 Ashley Rd, Altrincham
Cheshire X0 WA14 2DT
Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2021-06-02 1,000 $20.00 1,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.